Phase 1 Study of F182112 in Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT04984434 · UNKNOWN

Trial details

NCT number: NCT04984434
Sponsor: Shandong New Time Pharmaceutical Co., LTD
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Dose-Escalation Study, Relapsed or Refractory Multiple Myeloma

Start date: 2021-07-30
Primary completion: 2023-07-30
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.